1. Home
  2. VREX vs MYGN Comparison

VREX vs MYGN Comparison

Compare VREX & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$10.35

Market Cap

440.9M

Sector

Technology

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.38

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
MYGN
Founded
2016
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
440.9M
444.2M
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
VREX
MYGN
Price
$10.35
$5.38
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$16.67
$7.64
AVG Volume (30 Days)
335.8K
1.5M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$811,000,000.00
$771,400,000.00
Revenue This Year
$5.35
$6.86
Revenue Next Year
$3.88
$5.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.33
52 Week Low
$6.76
$3.53
52 Week High
$14.57
$8.59

Technical Indicators

Market Signals
Indicator
VREX
MYGN
Relative Strength Index (RSI) 47.51 69.85
Support Level $10.18 $4.24
Resistance Level $12.60 $5.52
Average True Range (ATR) 0.52 0.30
MACD 0.01 0.10
Stochastic Oscillator 25.84 92.02

Price Performance

Historical Comparison
VREX
MYGN

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: